Keyphrases
5-year Survival
14%
Adjusted Odds Ratio
15%
Advanced Prostate Cancer
14%
Aggressive Prostate Cancer
9%
Biochemical Recurrence
27%
Black Americans
15%
Black Men
25%
Black Women
10%
Body Mass Index
12%
Breast Cancer
14%
Breast Cancer Mortality
11%
Cancer Mortality
17%
Cancer Risk
17%
Colorectal Cancer
14%
Confidence Interval
40%
Definitive Treatment
18%
Diabetes
15%
Diverse Populations
9%
Electronic Medical Records
14%
Ethnic Differences
14%
Hazard Ratio
26%
Inverse Association
9%
Lung Cancer
14%
Marital Status
17%
Metformin Use
21%
Nationally Representative Study
14%
North Carolina
13%
Obesity
18%
Patient Survival
14%
Population-based Study
14%
Post-diagnostic Support
14%
Prospective Cohort Study
10%
Prostate Cancer
78%
Prostate Cancer Aggressiveness
25%
Prostate Cancer Patients
10%
Prostate Cancer Recurrence
14%
Prostate Cancer Risk
13%
Prostate Cancer Screening
14%
Prostate-specific Antigen Testing
14%
Racial Differences
22%
Racially Diverse
9%
Radical Prostatectomy
21%
Rural-urban
17%
Statin Use
14%
Surveillance Epidemiology
17%
United States
10%
Veterans Health Administration
9%
Weight Change
8%
White Americans
16%
White People
19%
Medicine and Dentistry
4 Iodo 2,5 Dimethoxyamphetamine
7%
Adverse Effect
7%
Antigen
7%
Apoplexy
7%
Breast Cancer
28%
Cancer Growth
8%
Cancer Mortality
17%
Cancer Prevention
6%
Cancer Screening
9%
Cancer Types
5%
Clinician
6%
Cohort Effect
14%
Colorectal Carcinoma
14%
Diabetes
14%
Disease Exacerbation
7%
Diseases
7%
Electronic Patient Record
7%
Financial Toxicity
7%
Glycon
7%
Hazard Ratio
15%
Health Care
9%
Local Therapy
7%
Logistic Regression Analysis
9%
Lung Cancer
14%
Malignant Neoplasm
27%
Marital Status
14%
Medical Record
8%
Meta-Analysis
7%
Metastatic Breast Cancer
7%
Neoplasm
17%
Odds Ratio
16%
Oncology
7%
Otitis Media
7%
Pediatric Brain Tumor
7%
Physical Activity
7%
Prevalence
8%
Prognostic Factor
7%
Proportional Hazards Model
6%
Prostate Cancer
100%
Prostate Specific Antigen
8%
Prostatectomy
11%
Prostatitis
7%
Race Difference
22%
Racial Disparity
7%
Screening
7%
Surveillance, Epidemiology, and End Results
16%
Survivorship in Cancer Care
7%
Systematic Review
7%
Urban Population
7%
Veterans Health
7%